PTCB Technician Product Verification Certificate Examination Practice Test
Product verification focuses on confirming that the medication selected for dispensing matches the prescription and is suitable for use. Practice questions address product identity, strength and concentration, dosage form, packaging integrity, expiration dates, manufacturer details, and lot information—checks that help identify discrepancies before a product reaches the pharmacist for final review.
Exam overview
About the PTCB Technician Product Verification Certificate Examination Exam
Verification requires comparing the prescription with the stock product rather than relying on a familiar name or a single matching detail. A technician must distinguish concentration from total amount, notice when a selected liquid’s strength differs from the prescribed concentration, and recognize that matching active ingredients and strengths may not resolve questions about brand interchangeability or device compatibility. Packaging condition and legibility also matter: damaged unit-dose packaging, unreadable product labels, or unclear lot information can prevent confident identification or traceability. Expiration dates should be assessed against the planned treatment period, not just the dispensing date. When a product’s identity, equivalence, or suitability is uncertain, the appropriate workflow is to stop the verification step and refer the question to the pharmacist or follow pharmacy procedure rather than make an unsupported substitution.
Sample Practice Questions
Review a selection from this exam's published US Practice Tests practice bank.
During final verification, the product’s printed lot number is unreadable, but the product name and strength are legible. What is the best response?
Show answer
Correct answer: BAn unreadable lot number can interfere with traceability, including responding to a recall or quality concern. The product should be set aside while staff follow established procedures; information must never be guessed or copied from another package.
A prescription specifies a brand-name medication, and the selected product is a generic with the same active ingredient and strength. What should the technician do when interchangeability is uncertain?
Show answer
Correct answer: BBrand and generic substitution depends on the product and applicable requirements. A technician should refer uncertain interchangeability or substitution decisions to the pharmacist rather than making an independent clinical determination.
A prescription is for a 100 mg/5 mL liquid. The selected bottle is labeled 100 mg/mL. Which statement is correct?
Show answer
Correct answer: BA concentration of 100 mg/mL contains five times as much drug per milliliter as 100 mg/5 mL. This is a meaningful concentration difference and must be resolved by the pharmacist before the product is used.
A selected package has an expiration date that falls before the patient’s planned end of therapy. What is the best action?
Show answer
Correct answer: BThe product should remain usable through the intended course of therapy. Select a suitable package with an appropriate expiration date, or escalate the issue; do not alter the prescription independently.
A medication product has a manufacturer lot number printed on its package. What is the primary purpose of recording or retaining lot information according to pharmacy procedure?
Show answer
Correct answer: BLot numbers help identify specific product batches. Traceability is important if a manufacturer or regulator issues a recall or an investigation requires identifying affected stock or dispensed products.
A prescription is for a medication in a blister pack. One cavity is punctured, exposing its contents. What is the appropriate product-verification action?
Show answer
Correct answer: CDamaged packaging can compromise product integrity or protection. The affected package should be set aside and handled according to pharmacy procedure rather than repaired or repackaged without authorization.
A stock bottle has a label that is difficult to read, and the product identity cannot be confidently confirmed. What should happen before the product is used?
Show answer
Correct answer: CA product must be positively identified before use. Location and appearance alone are not reliable substitutes for readable, verifiable labeling; follow pharmacy procedure to replace or otherwise address the unclear stock.
How to use this practice test
The free practice bank contains 50 questions, with up to 20 randomly selected for a session. Use each session to test product-to-prescription comparisons, concentration interpretation, package and label checks, and decisions about when uncertainty requires escalation. Results appear after the session so you can identify which verification decisions need further review.
Preparation tips
- Compare the prescribed strength and concentration with the product label, keeping units and denominators explicit; for example, distinguish mg/mL from mg per 5 mL.
- Practice identifying mismatches in active ingredient, dosage form, strength, package, and delivery-device components instead of treating a similar product name as sufficient.
- Review how your pharmacy handles unreadable labels, damaged blister cavities, missing or unclear lot details, and products that cannot be confidently identified.
- Work through expiration-date scenarios by comparing the product’s usable period with the anticipated end of therapy, then identify when pharmacist review is needed.
- For uncertain generic substitution or product equivalence, practice pausing the workflow and escalating the question rather than assuming that a shared ingredient and strength settle the issue.